Clinical Trial Update: Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 safety trial comparing single versus multiple-dose thymoglobulin induction in kidney transplantation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Wright State University | Conditions: End-Stage Renal Disease, Kidney Failure | Phase 2 | Status: COMPLETED | Results posted: 2015-12-07